U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07011992) titled 'A Study to Assess the Effects of BPN14770 on Rosuvastatin' on June 02.
Brief Summary: The primary objective of this study is to investigate the effects of BPN14770 on the pharmacokinetics of the breast cancer resistance protein and organic anion transporting polypeptide 1B1 substrate rosuvastatin in healthy adults.
Study Start Date: June 09
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Rosuvastatin
Oral tablet
DRUG: BPN14770
Oral capsule
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shionogi
Disclaimer: Curated by HT Syndication....